SAN DIEGO, Jun 09, 2010 (BUSINESS WIRE) --Illumina, Inc. (NASDAQ:ILMN) announced today that it will webcast the company's presentation at the Goldman Sachs Global Healthcare Conference in Los Angeles, California, on June 16, 2010. The live webcast is scheduled to begin at 1 p.m. ET and will feature an overview of the company by Jay Flatley, president and chief executive officer, followed by a brief question and answer session.
The live webcast can be accessed under the "Corporate/Investor Information" tab of Illumina's web site at http://www.illumina.com.
About Illumina
Illumina (http://www.illumina.com) is a leading developer, manufacturer, and marketer of life-science tools and integrated systems for the large-scale analysis of genetic variation and biological function. Using our proprietary technologies, we provide a comprehensive line of products and services that currently serve the sequencing, genotyping, and gene expression markets, and we expect to enter the market for molecular diagnostics. Our customers include leading genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies. Our tools provide researchers around the world with the performance, throughput, cost effectiveness, and flexibility necessary to perform the billions of genetic tests needed to extract valuable medical information from advances in genomics and proteomics. We believe this information will enable researchers to correlate genetic variation and biological function, which can enhance drug discovery and clinical research, may eventually allow diseases to be detected earlier, and permit better choices of drugs for individual patients.
SOURCE: Illumina, Inc.
Illumina, Inc.
Investors:
Peter J. Fromen
Sr. Director, Investor Relations
+858-202-4507
pfromen@illumina.com
or
Media:
Wilson Grabill
Public Relations
+858-882-6822
wgrabill@illumina.com
